Clinical efficacy and safety: blood and blood-forming organs
The European Medicines Agency's scientific guidelines on the clinical evaluation of human medicines used in conditions affecting the blood and blood-forming organs help medicine developers prepare marketing authorisation applications.
For a complete list of scientific guidelines currently open for consultation, see Public consultations.
- Clinical development of medicinal products intended for the treatment of chronic primary immune thrombocytopenia
Points to consider
- Endpoints in clinical studies with haematopoietic growth factors for mobilisation of autologous stem cells